Louise Cookson

601 total citations
7 papers, 389 citations indexed

About

Louise Cookson is a scholar working on Molecular Biology, Nephrology and Oncology. According to data from OpenAlex, Louise Cookson has authored 7 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Nephrology and 3 papers in Oncology. Recurrent topics in Louise Cookson's work include Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers), Parathyroid Disorders and Treatments (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Louise Cookson is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers), Parathyroid Disorders and Treatments (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Louise Cookson collaborates with scholars based in United Kingdom, United States and Germany. Louise Cookson's co-authors include Duncan Richards, James M. Ritter, Mark B. Pepys, Thirusha Lane, Marianna Fontana, Julian D. Gillmore, Philip N. Hawkins, James Moon, Aliénor Berges and Massimo Pinzani and has published in prestigious journals such as New England Journal of Medicine, Blood and Science Translational Medicine.

In The Last Decade

Louise Cookson

7 papers receiving 385 citations

Peers

Countries citing papers authored by Louise Cookson

Since Specialization

Citations

This map shows the geographic impact of Louise Cookson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise Cookson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise Cookson more than expected).

Fields of papers citing papers by Louise Cookson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louise Cookson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise Cookson. The network helps show where Louise Cookson may publish in the future.

Co-authorship network of co-authors of Louise Cookson

This figure shows the co-authorship network connecting the top 25 collaborators of Louise Cookson. A scholar is included among the top collaborators of Louise Cookson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise Cookson. Louise Cookson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	An observational, non-interventional study for the follow-up of patients with amyloidosis who received miridesap followed by dezamizumab in a phase 1 study 2022 ·Orphanet Journal of Rare Diseases ·Duncan Richards, Helen Millns, Louise Cookson, Mary Ann Lukas	7
2	Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis 2018 ·Science Translational Medicine ·Duncan Richards, Louise Cookson, (unknown), Lia Liefaard, Thirusha Lane, David F. Hutt, James M. Ritter, Marianna Fontana, James Moon, Julian D. Gillmore, Ashutosh Wechalekar, Philip N. Hawkins, Mark B. Pepys	94
3	Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Intravenous Dose of Miridesap in Healthy Japanese Subjects 2018 ·Clinical Pharmacology in Drug Development ·(unknown), Yohei Doi, Lia Liefaard, Louise Cookson, Chao Chen, Hiroshi Itoh, (unknown), (unknown)	2
4	Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component 2015 ·New England Journal of Medicine ·Duncan Richards, Louise Cookson, Aliénor Berges, (unknown), Thirusha Lane, James M. Ritter, Marianna Fontana, James Moon, Massimo Pinzani, Julian D. Gillmore, Philip N. Hawkins, Mark B. Pepys	261
5	Dose-Dependent Progressive Immunotherapeutic Clearance of Systemic Amyloid Deposits By Repeated Doses of Antibody to Serum Amyloid P Component (SAP) 2015 ·Blood ·Mark B. Pepys, Louise Cookson, (unknown), Aliénor Berges, Thirusha Lane, David F. Hutt, Marianna Fontana, James Moon, Julian D. Gillmore, Ashutosh Wechalekar, Philip N. Hawkins, Duncan Richards	2
6	Target Mediated Drug Disposition Model of CPHPC in Patients with Systemic Amyloidosis 2015 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), Aliénor Berges, (unknown), Louise Cookson, Stefano Zamuner, Duncan Richards	9
7	The Effect of Intravenous Infusion of Adenosine on Electrically Evoked Hyperalgesia in a Healthy Volunteer Model of Central Sensitization 2004 ·Anesthesia & Analgesia ·Boris A. Chizh, Martin Dusch, (unknown), Martin Schmelz, Louise Cookson, Reynaldo Martina, John H. Brown, Wolfgang Koppert	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact